Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Selvigaltin (GB1211) | 1978336-95-6 | 99.9% | 533.32 | 25 MG
SDP

Catalog No. 5000363467
Encompass_Preferred

Selvigaltin (GB1211) is an orally active small molecule inhibitor of galectin-3. It demonstrates anti-tumor activity and is effective at reducing galectin-3 levels in the liver. It also decreases biomarkers of liver function, inflammation, and fibrosis, while restoring T-cell activity.

  • Reduces galectin-3 levels in the liver
  • Decreases biomarkers of liver function (AST, ALT, bilirubin)
  • Lowers inflammation markers (cells foci)
  • Reduces fibrosis biomarkers (PSR, SHG)
  • Decreases mRNA and protein expression of IL6, TGFβ3, SNAI2, and collagen
  • Restores T-cell activity
  • Leads to fewer tumors and metastasis

Catalog No. 50-003-63467 Supplier Medchemexpress LLC Supplier No. 25MGHY147041
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Selvigaltin (GB1211) is an orally active small molecule inhibitor of galectin-3. It demonstrates anti-tumor activity and is effective at reducing galectin-3 levels in the liver. It also decreases biomarkers of liver function, inflammation, and fibrosis, while restoring T-cell activity.

  • Reduces galectin-3 levels in the liver
  • Decreases biomarkers of liver function (AST, ALT, bilirubin)
  • Lowers inflammation markers (cells foci)
  • Reduces fibrosis biomarkers (PSR, SHG)
  • Decreases mRNA and protein expression of IL6, TGFβ3, SNAI2, and collagen
  • Restores T-cell activity
  • Leads to fewer tumors and metastasis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.